|
|
Actualités & Evénements
Actualités
|
21-déc.-2011
The December 2011 edition of the OECD's Key Biotechnology Indicators brings together the latest available economic and activity data on biotechnology and innovation, collected by OECD member and non-member countries. It builds on the extensive work of the OECD and national experts to improve the comparability of biotechnology statistics.
|
|
10-nov.-2011
This report describes the scientific, industrial, regulatory, and health care management system context in which biomarkers are being developed. It identifies some of the barriers which may impede biomarker research, discovery, development, commercialisation and, ultimately, uptake in clinics. It also focuses on the use of biomarkers in the health care system, as diagnostics and in medical tests, and explores the use of biomarkers for the development of improved medicines. It does not address the role of biomarkers upstream, as tools for basic research.
|
|
10-nov.-2011
This report explores the potential role of industrial biotechnology in the biobased economy. Along the way it examines emerging trends, the impact of innovation, the convergence of technologies, and goes on to identify the challenges involved. It concludes with a need for an integrated and strategic approach to allow industrial biotechnology to fulfil its potential as a force for good, not a panacea, in the struggle with climate change.
|
|
03-oct.-2011
This publication examines the international drivers, the enabling technologies fast-tracking industrial biotechnology, industry trends, some of the products that are appearing on the market, industry structure and finance, and policy measures and trends. It examines separately biofuels, biobased chemicals and bioplastics.
|
|
12-sept.-2011
This report explores how new and evolving approaches to IP, such as licensing and auctions, patents pools, IP clearinghouses and emerging models of research collaborations are impacting the modern scientific environment in life sciences. It suggests ways in which both the public and private sectors seek to evolve from an “own and protect” model of intellectual property into an era of “own and share”, where value accrues not just to the initial owner of IP, but also to larger society as a whole.
|
|
15-juin-2011
Le Projet de recommandation du Conseil de l’OCDE définit des principes qui guideront l’élaboration des méthodes d’évaluation de durabilité des bioproduits et de leurs intermédiaires. Cette recommandation s’adresse à tous ceux qui jouent un rôle dans l’innovation dans les bioindustries, en particulier à ceux qui évaluent l’impact des bioproduits en termes environnementaux, économiques et sociaux. Le public est invité à formuler des commentaires avant le 29 juillet 2011
|
|
06-déc.-2010
What are the potential economic impacts of nanotechnology, how are companies using nanotechnology for innovation, and what are the key challenges in its commercialisation? These are some of the questions that this book addresses, based on company case studies in several countries.
|
|
10-nov.-2010
The delivery of sustainable economic growth across multiple disciplines is a high priority on the policy agendas of the OECD member and non-member countries. Reviewing the industrial biotechnology innovation systems of these countries provides an excellent opportunity to evaluate the contribution to sustainable growth of this highly innovative and complex industrial sector. While the bio-based economy-related issues of OECD countries have been largely studied; those of the BRICS countries have not been duly addressed.
|
|
10-nov.-2010
The Workshop brought together policy makers, regulators, academic experts, private and public sector researcher and other interested parties, to discuss the latest biomedical developments such as stem cells and personalized medicine, and consider how to foster more effective health innovation. Participants concluded that there is a need to find new ways to pro-actively respond to biomedicine and health innovation.
|
|
05-oct.-2010
The Organisation for Economic Cooperation and Development (OECD) in partnership with the UK’s Economic and Social Research Council's (ESRC) Genomics Network (EGN) hosted a major Forum on 6-7 December 2010 at the OECD Headquarters in Paris. This Forum reviewed how knowledge in the life sciences is governed, shared, regulated and managed, and explored new linkages between the life sciences and information and communication technologies.
|
Evénements
|
du 12-mars-2012 au 13-févr.-2012
The OECD, in conjunction with Human Genome Organisation (HUGO) and the Australian Government, will be hosting two separate meetings related to Synthetic Biology in Sydney, Australia on 12 and 13 March 2012. Synthetic biology is a modular approach to building biological products that allows new products to be built, and tested better, faster and cheaper than existing approaches and on a larger scale. There are today a number of examples of products or processes derived from synthetic biology both in the laboratory and in production.
|
|
du 30-mai-2012 au 31-mai-2012
The OECD in partnership with Genome Canada, Genome British Columbia, Genome Atlantic, Health Canada, The Research Council of Norway, the Norwegian Ministry of Trade & Industry, and the Korean Ministry of Land, Transport and Maritime Affairs) will host a major conference on Marine Biotechnology on 30-31 May 2012 at the Wosk Centre for Dialogue, Vancouver, Canada.
This conference will review opportunities for marine biotechnology and look at how to realise these opportunities.
|
|
du 06-déc.-2010 au 07-déc.-2010
The Organisation for Economic Cooperation and Development (OECD) in partnership with the UK’s Economic and Social Research Council's (ESRC) Genomics Network (EGN) will host a major Forum on 6-7 December 2010 at the OECD Headquarters in Paris. This Forum will review how knowledge in the life sciences is governed, shared, regulated and managed, and to explore new linkages between the life sciences and information and communication technologies.
|
|
du 27-sept.-2010 au 28-sept.-2010
This workshop, to be held in Berlin, will bring together policy makers, researchers, clinicians and the private sector to discuss challenges in the governance of biomedical innovation. It will aim to help governments identify emerging issues and understand how their actions at local and international levels can help deliver biomedical innovation to achieve better health outcomes. It will provide a forum to compare and contrast the new governance and regulatory models that are emerging across the OECD area and elsewhere.
|
|
du 28-oct.-2010 au 29-oct.-2010
The delivery of sustainable economic growth across multiple disciplines is a high priority on the policy agendas of the OECD member and non-member countries. Reviewing the industrial biotechnology innovation systems of these countries provides an excellent opportunity to evaluate the contribution to sustainable growth of this highly innovative and complex industrial sector.
|
|
du 29-juin-2010 au 17-sept.-2010
Les biotechnologies industrielles et environmentales font partie des secteurs industriels de base, qui entraîne le passage des organismes principaux des secteurs manufacturiers (TI, pharmaceutique, chimique, automobile, textile, alimentation humaine et animale, agriculture, etc) vers les modèles économiques et environnementaux plus durable et plus écologique. Deux grands ateliers seront organisés dans ces domains.
|
|
du 16-sept.-2010 au 17-sept.-2010
The overall goal of the workshop is to understand the framework conditions that govern innovation in environmental biotechnology with a view to identifying and addressing inefficiencies. Workshop participants will include experts from industry, government, academia and international organisations, and non-governmental organisations.
|
Haut de la page
|
|
